A new clinical trial to test how a high dose of stem cells delivered via a method called retrograde coronary sinus infusion affects end-stage heart failure patients is showing promising results. The method involves giving the cells backwards (retrograde) through the heart through the main vein (the coronary sinus).
Please complete all fields of the form below, attach and upload your product release and a high-resolution (300 dpi and 6 inches wide) photo, and press submit.